Mupfudze, T. G., Handarova, D., Noreen, S. M., Stewart, D. E., Mohan, S., & Schold, J. D. (2025). Influence of Individual- and Area-Level Social Determinants of Health on Likelihood of Living Versus Deceased Donor Kidney Transplantation. Kidney International Reports, 10(3), 791–802. https://doi.org/10.1016/j.ekir.2024.12.011

Bomback, A. S., Charu, V., & Fakhouri, F. (2025). Challenges in the Diagnosis and Management of Immune Complex-Mediated Membranoproliferative Glomerulonephritis and Complement 3 Glomerulopathy. Kidney International Reports, 10(1), 17–28. https://doi.org/10.1016/j.ekir.2024.09.017

Weiss, R., Milo Rasouly, H., Marasa, M., Fernandez, H., Lin, F., & Sabatello, M. (2024). Nephrologists’ Views on a Workflow for Returning Genetic Results to Research Participants. Kidney International Reports, 9(11), 3278–3289. https://doi.org/10.1016/j.ekir.2024.08.026

Bomback, A. S., Daina, E., Remuzzi, G., Kanellis, J., Kavanagh, D., Pickering, M. C., Sunder-Plassmann, G., Walker, P. D., Wang, Z., Ahmad, Z., & Fakhouri, F. (2024). Efficacy and Safety of Pegcetacoplan in Kidney Transplant Recipients With Recurrent Complement 3 Glomerulopathy or Primary Immune Complex Membranoproliferative Glomerulonephritis. Kidney International Reports. https://doi.org/10.1016/j.ekir.2024.09.030

Kneifati-Hayek, J. Z., Zachariah, T., Ahn, W., Khan, A., Kiryluk, K., Mohan, S., Weng, C., Gharavi, A. G., & Nestor, J. G. (2024). Bridging the Gap in Genomic Implementation: Identifying User Needs for Precision Nephrology. Kidney International Reports, 9(8), 2420–2431. https://doi.org/10.1016/j.ekir.2024.05.032

Schweitzer, L., Miko, B. A., & Pereira, M. R. (2024). Infectious Disease Prophylaxis During and After Immunosuppressive Therapy. Kidney International Reports, 9(8), 2337–2352. https://doi.org/10.1016/j.ekir.2024.04.043

Schaefer, F., Al-Dakkak, I., Anokhina, K., Cohen, D., Greenbaum, L. A., & Ariceta, G. (2024). Global aHUS Registry Analysis of Patients Switching to Ravulizumab From Eculizumab. Kidney International Reports. https://doi.org/10.1016/j.ekir.2024.06.020

Chang, J.-H., Kudose, S., Droubi, S., Verduzco, H. A., Awori, J., Ratner, L. E., & Mohan, S. (2024). Four Cases of Kidney Transplants With Donor HCV-Derived Immune Complex Glomerulonephritis. Kidney International Reports, 9(6), 1903–1907. https://doi.org/10.1016/j.ekir.2024.04.010

Trimarchi, H., Barratt, J., Radhakrishnan, J., Rizk, D. V., Sorensen, B., Leiske, J., Khawaja, Z., Campbell, K., & Perkovic, V. (2024). WCN24-1837 BEYOND: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED TRIAL OF ZIGAKIBART IN ADULTS WITH IGA NEPHROPATHY. Kidney International Reports, 9(4), S177. https://doi.org/10.1016/j.ekir.2024.02.362

Ndife, B., Aldworth, C., Murphy, K. P., Nguyen, J., Pivneva, I., Edwards, M. L., Anderson, A., Signorovitch, J., & Canetta, P. (2024). WCN24-479 CHARACTERISTICS OF PATIENTS WITH COMPLEMENT 3 GLOMERULOPATHY (C3G) IN A US MULTI-CENTER ASSESSMENT. Kidney International Reports, 9(4), S243. https://doi.org/10.1016/j.ekir.2024.02.499

Ndife, B., Aldworth, C., Murphy, K. P., Nguyen, J., Pivneva, I., Edwards, M. L., Anderson, A., Signorovitch, J., & Canetta, P. (2024). WCN24-551 CKD PROGRESSION IN PATIENTS WITH COMPLEMENT 3 GLOMERULOPATHY (C3G) IN A US MULTI-CENTER ASSESSMENT. Kidney International Reports, 9(4), S244. https://doi.org/10.1016/j.ekir.2024.02.501

Quintana-Gallardo, L., Bomback, A., Daina, E., Kanellis, J., Kavanagh, D., Pickering, M. C., Sunder-Plassmann, G., Walker, P., Wang, Z., Ahmad, Z., & Fakhouri, F. (2024). WCN24-683 EFFICACY OF 12-WEEK PEGCETACOPLAN IN KIDNEY TRANSPLANT RECIPIENTS WITH RECURRENT C3 GLOMERULOPATHY (C3G) OR IMMUNE COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (IC-MPGN). Kidney International Reports, 9(4), S138–S139. https://doi.org/10.1016/j.ekir.2024.02.286

Zonozi, R., Aqeel, F., Le, D., Cortazar, F. B., Thaker, J., Zabala Ramirez, M. J., Sattui Cortes, S. E., Attieh, R. M., Chung, M., Bulbin, D. H., Shaikh, A., Guaman, K., Ford, J., Diffie, C., Gewurz-Singer, O., Sauvage, G., Jeyabalan, A., Geara, A., Ayoub, I., … Geetha, D. (2024). Real-World Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis. Kidney International Reports, 9(6), 1783–1791. https://doi.org/10.1016/j.ekir.2024.03.022

Avasare, R. S., Clark, S., Spain, R. I., Wusirika, R., Rope, R., Gurley, S., Stanaway, M., Sekulic, M., Santoriello, D., Bomback, A. S., Canetta, P., Iyer, S. J., Kung, V., Charu, V., Troxell, M. L., Kudose, S., & Andeen, N. K. (2024). Characteristics and Outcomes of NELL1 Membranous Nephropathy in Lipoic Acid Users and Nonusers. Kidney International Reports, 9(5), 1379–1386. https://doi.org/10.1016/j.ekir.2024.02.1401

Sekulic, M., Batal, I., Kudose, S., Santoriello, D., Stokes, M. B., Jim, B., Marti, H.-P., Eikrem, Ø., Radhakrishnan, J., D’Agati, V. D., & Markowitz, G. S. (2024). Kidney Dysfunction and Pathology in the Setting of Hemophagocytic Lymphohistiocytosis. Kidney International Reports, 9(2), 410–422. https://doi.org/10.1016/j.ekir.2023.10.033

Nakatsugawa, A. C., & Sampogna, R. V. (2024). Postnatal Nephrogenesis in Preterm Infants: The Need to Safeguard Kidney Development After Birth. Kidney International Reports, 9(2), 201–202. https://doi.org/10.1016/j.ekir.2023.12.013

Buchalter, R. B., Mohan, S., & Schold, J. D. (2024). Geospatial Modeling Methods in Epidemiological Kidney Research: An Overview and Practical Example. Kidney International Reports, 9(4), 807–816. https://doi.org/10.1016/j.ekir.2024.01.017

Andeen, N. K., DiFranza, L., Kung, V. L., Henriksen, K., Gupta, R., Dinesh, K., Akilesh, S., Kudose, S., Smith, K. D., & Troxell, M. L. (2024). AA amyloidosis With Ig-Dominant Staining and Diagnostically Unusual Features. Kidney International Reports, 9(1), 162–170. https://doi.org/10.1016/j.ekir.2023.10.005

Blasco, M., & Bomback, A. S. (2024). Complement and Podocytopathies: Do We Have a New Biomarker? Kidney International Reports, 9(3), 520–522. https://doi.org/10.1016/j.ekir.2024.01.037

Dube, G. K. (2024). Early Stops on the Road to Transplant: Lessons From the German Transplantation Registry. Kidney International Reports, 9(1), 7–9. https://doi.org/10.1016/j.ekir.2023.11.010

Calì, F., & Pinsino, A. (2024). Heart Failure Guideline-Directed Medical Therapy in End-Stage Kidney Disease: From PARADIGM-HF to Clinical Practice. Kidney International Reports, 9(1), 13–15. https://doi.org/10.1016/j.ekir.2023.11.015

Tarragon Estebanez, B., & Bomback, A. S. (2024). C3 Glomerulopathy: Novel Treatment Paradigms. Kidney International Reports, 9(3), 569–579. https://doi.org/10.1016/j.ekir.2023.12.007

Kudose, S., Sekulic, M., Walavalkar, V., Batal, I., Stokes, M. B., Markowitz, G. S., D’Agati, V. D., & Santoriello, D. (2023). Immunofluorescence Staining for IgG Subclass: Cause for Discrepancy in the Detection of IgG1. Kidney International Reports, 8(11), 2416–2420. https://doi.org/10.1016/j.ekir.2023.08.015

Vivarelli, M., Bomback, A. S., Meier, M., Wang, Y., Webb, N. J. A., Veldandi, U. K., Smith, R. J. H., & Kavanagh, D. (2024). Iptacopan in Idiopathic Immune Complex–Mediated Membranoproliferative Glomerulonephritis: Protocol of the APPARENT Multicenter, Randomized Phase 3 Study. Kidney International Reports, 9(1), 64–72. https://doi.org/10.1016/j.ekir.2023.10.022

Tesař, V., Radhakrishnan, J., Charu, V., & Barratt, J. (2023). Challenges in IgA Nephropathy Management: An Era of Complement Inhibition. Kidney International Reports, 8(9), 1730–1740. https://doi.org/10.1016/j.ekir.2023.06.010

Cortazar, F. B., Cerda, J., Dhanani, R., Roglieri, J., & Santoriello, D. (2023). Avacopan in Patients With Rapidly Progressive Glomerulonephritis Requiring Dialysis. Kidney International Reports, 8(8), 1687–1691. https://doi.org/10.1016/j.ekir.2023.05.017

Kudose, S., Cossey, L. N., Canetta, P. A., Sekulic, M., Vanbeek, C. A., Huls, F. B., Gupta, I., Bu, L., Alexander, M. P., Cornell, L. D., Fidler, M. E., Markowitz, G. S., Larsen, C. P., D’Agati, V. D., Nasr, S. H., & Santoriello, D. (2023). Clinicopathologic Spectrum of Lysozyme-Associated Nephropathy. Kidney International Reports, 8(8), 1585–1595. https://doi.org/10.1016/j.ekir.2023.05.007

Marasa, M., Ahram, D. F., Rehman, A. U., Mitrotti, A., Abhyankar, A., Jain, N. G., Weng, P. L., Piva, S. E., Fernandez, H. E., Uy, N. S., Chatterjee, D., Kil, B. H., Nestor, J. G., Felice, V., Robinson, D., Whyte, D., Gharavi, A. G., Appel, G. B., Radhakrishnan, J., … Sanna-Cherchi, S. (2023). Implementation and Feasibility of Clinical Genome Sequencing Embedded Into the Outpatient Nephrology Care for Patients With Proteinuric Kidney Disease. Kidney International Reports, 8(8), 1638–1647. https://doi.org/10.1016/j.ekir.2023.05.021

Santoriello, D., Ramaswamy, R., Kudose, S., & Markowitz, G. S. (2023). Segmental NELL-1 Membranous Nephropathy Complicating Tiopronin Therapy. Kidney International Reports, 8(8), 1683–1686. https://doi.org/10.1016/j.ekir.2023.05.023

Zubidat, D., Madden, B., Kudose, S., Nasr, S. H., Nardelli, L., Fervenza, F. C., & Sethi, S. (2023). Heterogeneity of Target Antigens in Sarcoidosis-Associated Membranous Nephropathy. Kidney International Reports, 8(6), 1213–1219. https://doi.org/10.1016/j.ekir.2023.03.019

Mohan, S., Yu, M., King, K. L., & Husain, S. A. (2023). Increasing Discards as an Unintended Consequence of Recent Changes in United States Kidney Allocation Policy. Kidney International Reports, 8(5), 1109–1111. https://doi.org/10.1016/j.ekir.2023.02.1081

Reynolds, M. L., Oliverio, A. L., Zee, J., Hendren, E. M., O’Shaughnessy, M. M., Ayoub, I., Almaani, S., Vasylyeva, T. L., Twombley, K. E., Wadhwani, S., Steinke, J. M., Rizk, D. V., Waldman, M., Helmuth, M. E., Avila-Casado, C., Alachkar, N., Nester, C. M., Derebail, V. K., Hladunewich, M. A., & Mariani, L. H. (2023). Pregnancy History and Kidney Disease Progression Among Women Enrolled in Cure Glomerulonephropathy. Kidney International Reports, 8(4), 805–817. https://doi.org/10.1016/j.ekir.2023.01.036

King, K. L., Yu, M., Husain, S. A., Patzer, R. E., Sandra, V., Reese, P. P., Schold, J. D., & Mohan, S. (2023). Contribution of Estimates of Glomerular Filtration to the Extensive Disparities in Preemptive Listing for Kidney Transplant. Kidney International Reports, 8(3), 442–454. https://doi.org/10.1016/j.ekir.2022.12.021

Ravipati, P., Freese, R. L., Royal, V., Bu, L., Canetta, P., Gipson, D., Kallash, M., Kiryluk, K., Nast, C., Reich, H. N., Rheault, M. N., Saha, M., & Nachman, P. H. (2022). Clinicopathologic Significance of Predominant Lambda Light Chain Deposition in IgA Nephropathy. Kidney International Reports, 7(11), 2462–2473. https://doi.org/10.1016/j.ekir.2022.08.003

Bomback, A. S., Kavanagh, D., Vivarelli, M., Meier, M., Wang, Y., Webb, N. J. A., Trapani, A. J., & Smith, R. J. H. (2022). Alternative Complement Pathway Inhibition With Iptacopan for the Treatment of C3 Glomerulopathy-Study Design of the APPEAR-C3G Trial. Kidney International Reports, 7(10), 2150–2159. https://doi.org/10.1016/j.ekir.2022.07.004

Jain, N. G., Ahram, D. F., Marasa, M., Rehman, A. U., May, H. J., Zacharoulis, S., Revah-Politi, A., Florido, M. E., Whittemore, G. B., Aggarwal, V. S., Hargus, G., Anyane-Yeboa, K., D’Agati, V. D., Lin, F., Jobanputra, V., & Sanna-Cherchi, S. (2022). Clinical Real-Time Genome Sequencing to Solve the Complex and Confounded Presentation of a Child With Focal Segmental Glomerulosclerosis and Multiple Malignancies. Kidney International Reports, 7(10), 2312–2316. https://doi.org/10.1016/j.ekir.2022.07.174

Jagannathan, G., Markowitz, G. S., Sheth, N. D., & Kudose, S. (2022). Concurrent PLA2R-Associated Membranous Nephropathy and Antiglomerular Basement Membrane Disease. Kidney International Reports, 7(10), 2308–2311. https://doi.org/10.1016/j.ekir.2022.07.006

Guber, K., & Kirtane, A. J. (2022). Renal Sympathetic Denervation for Hypertension. Kidney International Reports, 7(10), 2129–2140. https://doi.org/10.1016/j.ekir.2022.06.019

Floege, J., Gibson, K. L., Praga, M., Radhakrishnan, J., Reich, H. N., Schreuder, M. F., Wetzels, J. F., Tesař, V., Vivarelli, M., Biechele, S., & Tonelli, M. (2022). Diagnosis and Treatment of Patients With Focal Segmental Glomerulosclerosis/Steroid-Resistant Nephrotic Syndrome: A Delphi Survey. Kidney International Reports, 7(9), 2081–2085. https://doi.org/10.1016/j.ekir.2022.06.010

Floege, J., Barratt, J., Coppo, R., Lafayette, R., Radhakrishnan, J., Reich, H. N., Rovin, B. H., Selewski, D. T., Vivarelli, M., Pham, C., & Tesař, V. (2022). International Physicians Delphi Survey: Managing Patients With IgA Nephropathy. Kidney International Reports, 7(9), 2076–2080. https://doi.org/10.1016/j.ekir.2022.05.022

Barratt, J., Tumlin, J., Suzuki, Y., Kao, A., Aydemir, A., Pudota, K., Jin, H., Gühring, H., & Appel, G. (2022). Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria. Kidney International Reports, 7(8), 1831–1841. https://doi.org/10.1016/j.ekir.2022.05.017

Smith, R., Kavanagh, D., Tawfiq, R., Trapani, A. J., Wang, Y., Webb, N. J., Meier, M., Vivarelli, M., & Bomback, A. (2022). POS-038 ALTERNATIVE COMPLEMENT PATHWAY INHIBITION WITH IPTACOPAN TO ARREST DISEASE PROGRESSION IN C3 GLOMERULOPATHY (APPEAR-C3G): A PHASE 3 STUDY. Kidney International Reports, 7(6), S454–S455. https://doi.org/10.1016/j.ekir.2022.04.060

Kudose, S., Jagannathan, G., Santoriello, D., Sekulic, M., Batal, I., Stokes, M. B., D’Agati, V. D., & Markowitz, G. S. (2022). Validation Study on the Utility of Immunoglobulin Heavy/Light Chain Immunofluorescence in Kidney Biopsies With Potential Monoclonal Gammopathy of Renal Significance Lesions. Kidney International Reports, 7(5), 1119–1122. https://doi.org/10.1016/j.ekir.2022.01.1071

Verduzco, H. A., Batal, I., Mohan, S., & Husain, S. A. (2022). Reproducibility of Chronic Changes on High-Quality Deceased Donor Kidney Allograft Biopsies. Kidney International Reports, 7(4), 889–891. https://doi.org/10.1016/j.ekir.2021.12.022

Bomback, A., Herlitz, L. C., Yue, H., Kedia, P. P., Schall, T. J., & Bekker, P. (2022). POS-112 EFFECT OF AVACOPAN, A SELECTIVE C5A RECEPTOR INHIBITOR, ON COMPLEMENT 3 GLOMERULOPATHY HISTOLOGIC INDEX OF DISEASE CHRONICITY. Kidney International Reports, 7(2), S47–S48. https://doi.org/10.1016/j.ekir.2022.01.124

Carter, S. A., Teng, C., Gutman, T., Logeman, C., Cattran, D., Lightstone, L., Bagga, A., Barbour, S. J., Barratt, J., Boletis, J., Caster, D. J., Coppo, R., Fervenza, F. C., Floege, J., Hladunewich, M. A., Hogan, J. J., Kitching, A. R., Lafayette, R. A., Malvar, A., … Tong, A. (2022). A Focus Group Study of Self-Management in Patients With Glomerular Disease. Kidney International Reports, 7(1), 56–67. https://doi.org/10.1016/j.ekir.2021.10.011

Dube, G. K., Benvenuto, L. J., & Batal, I. (2021). Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis Following the Pfizer-BioNTech COVID-19 Vaccine. Kidney International Reports, 6(12), 3087–3089. https://doi.org/10.1016/j.ekir.2021.08.012

Xu, K., Shang, N., Levitman, A., Corker, A., Kudose, S., Yaeh, A., Neupane, U., Stevens, J., Sampogna, R., Mills, A. M., D’Agati, V., Mohan, S., Kiryluk, K., & Barasch, J. (2021). Elevated Neutrophil Gelatinase-Associated Lipocalin Is Associated With the Severity of Kidney Injury and Poor Prognosis of Patients With COVID-19. Kidney International Reports, 6(12), 2979–2992. https://doi.org/10.1016/j.ekir.2021.09.005